Blocktech Ventures
San Jose, United States1
1M
1
- Areas of investment
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Investments by industry
- Payments (1)
- Investments by region
- United States (1)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 1
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Coinflow Labs | 19 Apr 2023 | Payments | Seed | 1M | United States, Illinois, Chicago |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Mirador Therapeutics , a San Diego, CA-based clinical-stage precision medicine company developing new therapies for immune-mediated inflammatory and fibrotic diseases | Jan 13, 2026 | Immunology, Inflammation, Precision Medicine | - | 250000000 USD | CA-based clinical-stage precision medicine company, a San Diego |
| SeraGene Therapeutics | Nov 20, 2025 | Biotechnology, Lipid nanoparticles (LNPs), Lipid Nanoparticles (LNPs), Preclinical-stage, RNA technology, RNA Technology, siRNAs | - | - | .svg) Vancouver, British Columbia |
| Credit Genie | Oct 23, 2023 | AI, Behavioral Finance, Budgeting, Cash/Credit Management, Credit-Building Solutions, Credit Risk Prediction, Data Analysis Technology, Digital Personal Finance, Digital Personal Finance Platform, Financial Alerts and Insights, Financial Membership Platform, Financial Snapshot App, Machine Learning, Mobile Financial Membership Platform, Personalized Budgeting | - | 10000000 USD | Plymouth Meeting, Pennsylvania |
| Incyclix Bio | Apr 4, 2022 | Biotechnology, Cancer Therapeutics, Cancer Treatment, CDK2 Inhibitor, Cell Cycle Control, Cyclin-Dependent Kinases, Precision Medicine | Mid stage | 30000000 USD | Research Triangle Park, North Carolina |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.